Cargando…

Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview

The prevalence of heart failure with preserved ejection fraction (HFpEF) is steadily increasing. Its diagnosis remains difficult and controversial and relies mostly on non-invasive echocardiographic detection of left ventricular diastolic dysfunction and elevated filling pressures. The large phenoty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michalska-Kasiczak, Marta, Bielecka-Dabrowa, Agata, von Haehling, Stephan, Anker, Stefan D., Rysz, Jacek, Banach, Maciej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2018
Materias:	State of the Art Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040115/ https://www.ncbi.nlm.nih.gov/pubmed/30002709 http://dx.doi.org/10.5114/aoms.2018.76279

Ejemplares similares

The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2017)

Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2015)

The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2015)

Menopause and women’s cardiovascular health: is it really an obvious relationship?
por: Ryczkowska, Kamila, et al.
Publicado: (2022)

The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2023)

Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology
por: Anker, Markus S., et al.
Publicado: (2013)

Sudden Death and Ventricular Arrhythmias in Heart Failure With Preserved Ejection Fraction
por: Cho, Jae Hyung
Publicado: (2022)

Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2013)

The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy – 5-year follow-up
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2013)

Murine Models of Heart Failure With Preserved Ejection Fraction: A “Fishing Expedition”
por: Valero-Muñoz, Maria, et al.
Publicado: (2017)

Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
por: Salah, Husam M., et al.
Publicado: (2021)

Lipids, blood pressure, kidney – what was new in 2011?
por: Barylski, Marcin, et al.
Publicado: (2011)

Malignancy-Associated Dyslipidemia
por: Bielecka-Dąbrowa, Agata, et al.
Publicado: (2011)

The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2011)

Diagnostic Usefulness of Spiroergometry and Risk Factors of Long COVID in Patients with Normal Left Ventricular Ejection Fraction
por: Gryglewska-Wawrzak, Katarzyna, et al.
Publicado: (2023)

Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
por: Rysz-Górzyńska, Magdalena, et al.
Publicado: (2016)

Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models
por: van Ham, Willem B., et al.
Publicado: (2022)

Factors of Persistent Limited Exercise Tolerance in Patients after COVID-19 with Normal Left Ventricular Ejection Fraction
por: Gryglewska-Wawrzak, Katarzyna, et al.
Publicado: (2022)

Molecular mechanisms of statin intolerance
por: Gluba-Brzozka, Anna, et al.
Publicado: (2016)

Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: Rosalia, Luca, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models
por: Withaar, Coenraad, et al.
Publicado: (2021)

Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction
por: Sinha, Aish, et al.
Publicado: (2021)

The mechanisms of atrial fibrillation in hyperthyroidism
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2009)

Correction to: Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2020)

Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2019)

Medical Management of Patients With Heart Failure and Reduced Ejection Fraction
por: Greenberg, Barry
Publicado: (2022)

Update of treatment of heart failure with reduction of left ventricular ejection fraction
por: Aronow, Wilbert S.
Publicado: (2016)

Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology
por: Gąsiorek, Paulina, et al.
Publicado: (2019)

Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications
por: Bikiewicz, Agata, et al.
Publicado: (2021)

Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study
por: Bielecka-Dąbrowa, Agata, et al.
Publicado: (2010)

Established and potential echocardiographic markers of embolism and their therapeutic implications in patients with ischemic stroke
por: Gąsiorek, Paulina E., et al.
Publicado: (2019)

Markers of increased cardiovascular risk in patients with chronic kidney disease
por: Gluba-Brzózka, Anna, et al.
Publicado: (2014)

Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy
por: Stachowiak, Paweł, et al.
Publicado: (2013)

Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study
por: Gluba-Brzózka, Anna, et al.
Publicado: (2016)

Iron deficiency and cardiovascular disease
por: Savarese, Gianluigi, et al.
Publicado: (2022)

Empagliflozin in heart failure with preserved ejection fraction: first success in mission impossible
por: Sciatti, Edoardo, et al.
Publicado: (2022)

Erratum to: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study
por: Gluba-Brzózka, Anna, et al.
Publicado: (2016)

Factors and Prognostic Significance of Impaired Exercise Tolerance in Women over 40 with Arterial Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2021)

Neck pain in South Africa: An overview of the prevalence, assessment and management for the contemporary clinician
por: Basson, Cato A., et al.
Publicado: (2019)

Exosomes as nanocarriers for siRNA delivery: paradigms and challenges
por: Shahabipour, Fahimeh, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dv73lt6p67j3gj1ch4guaecibo